Covington Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.03M | Sell |
70,742
-7,336
| -9% | -$532K | 0.22% | 118 |
|
|
2022
Q2 | $6.01M | Sell |
78,078
-10,252
| -12% | -$781K | 0.24% | 113 |
|
|
2022
Q1 | $6.45M | Sell |
88,330
-815
| -0.9% | -$54.7K | 0.23% | 119 |
|
|
2021
Q4 | $5.56M | Sell |
89,145
-39,868
| -31% | -$2.34M | 0.19% | 128 |
|
|
2021
Q3 | $7.63M | Sell |
129,013
-5,990
| -4% | -$394K | 0.29% | 99 |
|
|
2021
Q2 | $9.02M | Sell |
135,003
-15,472
| -10% | -$1.01M | 0.35% | 86 |
|
|
2021
Q1 | $9.5M | Sell |
150,475
-13,545
| -8% | -$843K | 0.41% | 72 |
|
|
2020
Q4 | $10.2M | Buy |
164,020
+1,560
| +1% | +$95.9K | 0.46% | 63 |
|
|
2020
Q3 | $9.79M | Buy |
162,460
+2,614
| +2% | +$157K | 0.49% | 58 |
|
|
2020
Q2 | $9.4M | Buy |
159,846
+3,954
| +3% | +$237K | 0.52% | 53 |
|
|
2020
Q1 | $8.69M | Sell |
155,892
-3,736
| -2% | -$228K | 0.57% | 51 |
|
|
2019
Q4 | $10.2M | Buy |
159,628
+32,678
| +26% | +$1.87M | 0.54% | 53 |
|
|
2019
Q3 | $6.44M | Sell |
126,950
-20,025
| -14% | -$941K | 0.37% | 82 |
|
|
2019
Q2 | $6.67M | Buy |
146,975
+2,363
| +2% | +$110K | 0.4% | 77 |
|
|
2019
Q1 | $6.9M | Sell |
144,612
-725
| -0.5% | -$36.1K | 0.43% | 72 |
|
|
2018
Q4 | $7.55M | Buy |
145,337
+17,424
| +14% | +$936K | 0.53% | 56 |
|
|
2018
Q3 | $7.94M | Buy |
127,913
+24,095
| +23% | +$1.43M | 0.49% | 61 |
|
|
2018
Q2 | $5.75M | Buy |
103,818
+40,854
| +65% | +$2.21M | 0.37% | 81 |
|
|
2018
Q1 | $3.98M | Buy |
62,964
+3,050
| +5% | +$196K | 0.26% | 104 |
|
|
2017
Q4 | $3.67M | Buy |
59,914
+1,722
| +3% | +$108K | 0.23% | 105 |
|
|
2017
Q3 | $3.71M | Sell |
58,192
-3,268
| -5% | -$191K | 0.25% | 107 |
|
|
2017
Q2 | $3.42M | Sell |
61,460
-400
| -0.6% | -$21.8K | 0.28% | 101 |
|
|
2017
Q1 | $3.36M | Sell |
61,860
-38,068
| -38% | -$2.09M | 0.28% | 99 |
|
|
2016
Q4 | $5.84M | Sell |
99,928
-49,232
| -33% | -$2.69M | 0.52% | 72 |
|
|
2016
Q3 | $8.04M | Buy |
149,160
+7,260
| +5% | +$466K | 0.73% | 52 |
|
|
2016
Q2 | $10.4M | Buy |
141,900
+5,923
| +4% | +$419K | 0.97% | 31 |
|
|
2016
Q1 | $8.69M | Buy |
135,977
+11,081
| +9% | +$699K | 0.83% | 40 |
|
|
2015
Q4 | $8.59M | Buy |
124,896
+10,477
| +9% | +$692K | 0.84% | 40 |
|
|
2015
Q3 | $6.77M | Buy |
114,419
+41,568
| +57% | +$2.64M | 0.7% | 53 |
|
|
2015
Q2 | $4.85M | Buy |
72,851
+56,034
| +333% | +$3.69M | 0.43% | 75 |
|
|
2015
Q1 | $1.08M | Sell |
16,817
-282
| -2% | -$17.7K | 0.1% | 134 |
|
|
2014
Q4 | $1.01M | Sell |
17,099
-1,976
| -10% | -$111K | 0.09% | 152 |
|
|
2014
Q3 | $976K | Sell |
19,075
-8,762
| -31% | -$438K | 0.09% | 156 |
|
|
2014
Q2 | $1.35M | Sell |
27,837
-500
| -2% | -$24.6K | 0.12% | 135 |
|
|
2014
Q1 | $1.47M | Sell |
28,337
-150
| -0.5% | -$7.98K | 0.14% | 128 |
|
|
2013
Q4 | $1.51M | Hold |
28,487
| – | – | 0.15% | 129 |
|
|
2013
Q3 | $1.32M | Buy |
28,487
+400
| +1% | +$17.6K | 0.15% | 127 |
|
|
2013
Q2 | $1.25M | Buy |
+28,087
| New | +$1.22M | 0.15% | 123 |
|
Other funds holding BMY
Covington Capital Management's BMY Position: Q3 2022 in Review
Covington Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 9.4% in Q3 2022, selling an estimated $532K and leaving 70,742 shares worth $5.03M. The position accounts for 0.22% of the portfolio, ranked #118.
Covington Capital Management first reported a position in BMY in Q2 2013 and has held it in 38 quarters since. The position peaked at $10.4M in Q2 2016. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Covington Capital Management held 70,742 shares of Bristol-Myers Squibb worth $5.03M as of Q3 2022.
- Covington Capital Management sold 7,336 Bristol-Myers Squibb shares in Q3 2022, an estimated $532K.
- Bristol-Myers Squibb made up 0.22% of Covington Capital Management's portfolio in Q3 2022, its #118 holding.
- Covington Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Bristol-Myers Squibb position peaked at $10.4M in Q2 2016.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.